Global Custom Market Research Reports Provider Company


OSE Immunotherapeutics (OSE) - Financial and Strategic SWOT Analysis Review

  • Published Date: 09 Mar 2018
  • Number of Pages: 25
  • Category: Pharmaceuticals
  • Country: France

OSE Immunotherapeutics (OSE), formerly OSE Pharma SA is a biotechnology company that discovers and develops immunotherapy products against invasive and metastatic late-stage cancers. The companys memopi technology is employed in studying the development of treatments for ovarian, colon and breast cancer. Its products include tedopi and effi-7. OSEs Effi-7 is in preclinical development and targets autoimmune diseases and transplantation. The companys tedopi stimulates cytotoxic killer T cells and relearns them to detect cancer cells to eliminate them. It markets its products through its distribution network. OSE is headquartered in Nantes, France.

OSE Immunotherapeutics Key Recent Developments

Jan 03,2018: OSE Immunotherapeutics Announces Appointment of Gerard Tardy as Chairman of Companys Board of Directors
Sep 07,2017: OSE Immunotherapeutics Reports on First-Half 2017 Financial Results and Provides Update on Clinical Advances of Its Product Portfolio
May 18,2017: OSE Immunotherapeutics to Present at Annual Sachs Immuno-Oncology: BD&L and Investment Forum

This comprehensive SWOT profile of OSE Immunotherapeutics provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalDatas Profile on Demand service, covering over 50,000 of the worlds leading companies. Once purchased, GlobalDatas highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of OSE Immunotherapeutics including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief Summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Publisher Name : GlobalData

Section 1 - About the Company

OSE Immunotherapeutics - Key Information
OSE Immunotherapeutics - Overview
OSE Immunotherapeutics - Key Employees
OSE Immunotherapeutics - Key Employee Biographies
OSE Immunotherapeutics - Key Operational Heads
OSE Immunotherapeutics - Major Products and Services
OSE Immunotherapeutics - History
OSE Immunotherapeutics - Company Statement
OSE Immunotherapeutics - Locations And Subsidiaries
OSE Immunotherapeutics - Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 - Company Analysis

OSE Immunotherapeutics - Business Description
OSE Immunotherapeutics - Corporate Strategy
OSE Immunotherapeutics - SWOT Analysis
SWOT Analysis - Overview
OSE Immunotherapeutics - Strengths
OSE Immunotherapeutics - Weaknesses
OSE Immunotherapeutics - Opportunities
OSE Immunotherapeutics - Threats
OSE Immunotherapeutics - Key Competitors

Section 3 - Company Financial Performance Charts

OSE Immunotherapeutics - Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

Section 4 - Appendix

Ratio Definitions
About GlobalData
Contact Us

Note*: Some sections may be missing if data is unavailable for the company

List Of Tables

List of Tables

OSE Immunotherapeutics, Key Information
OSE Immunotherapeutics, Key Ratios
OSE Immunotherapeutics, Share Data
OSE Immunotherapeutics, Major Products and Services
OSE Immunotherapeutics, History
OSE Immunotherapeutics, Key Employees
OSE Immunotherapeutics, Key Employee Biographies
OSE Immunotherapeutics, Key Operational Heads
OSE Immunotherapeutics, Other Locations
OSE Immunotherapeutics, Subsidiaries
OSE Immunotherapeutics, Key Manufacturing facilities
OSE Immunotherapeutics, Key Competitors
OSE Immunotherapeutics, SWOT Analysis
OSE Immunotherapeutics, Ratios based on current share price
OSE Immunotherapeutics, Annual Ratios
OSE Immunotherapeutics, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

List of Figures

OSE Immunotherapeutics, Performance Chart
OSE Immunotherapeutics, Ratio Charts

Poly [ADP Ribose] Polymerase 1 (ADP Ribosyltransferase Diphtheria Toxin Like 1 or NAD(+) ADP Ribosyltransferase 1 or Poly[ADP Ribose] Synthase 1 or PARP1 or EC - Pipeline Review, H2

View Report

Neurofibromatoses Type II - Pipeline Review, H2 2018 Global Markets Directs latest Pharmaceutical and Healthcare disease pipeline guide Neurofibromatoses Type II - Pipeline Review, H2 2018, provides an overview of the

View Report

Drug Overdose - Pipeline Review, H2 2018 Global Markets Directs latest Pharmaceutical and Healthcare disease pipeline guide Drug Overdose - Pipeline Review, H2 2018, provides an overview of the Drug Overdose

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports